Chembond Material Technologies Ltd Q2 Revenue Rises 31.1%

Chembond Material Technologies Ltd, referred to as Chembond, reported consolidated Q2 revenue of ₹95.7 crore, 31.1% higher year on year from ₹73 crore. Consolidated net profit, however, declined 54.2% to ₹3.3 crore from ₹7.2 crore, showing that the higher top line did not translate into higher quarterly earnings.

What did Chembond report for Q2 FY27?

Chembond reported consolidated revenue of ₹95.7 crore for Q2 FY27, compared with ₹73 crore in the corresponding prior-year period. The reported increase works out to approximately 31.1% year on year. The company’s Q2 net profit was ₹3.3 crore, against ₹7.2 crore a year earlier, a decline of about 54.2%.

The figures were included in a market snapshot dated October 24, 2026. Separately, Chembond informed BSE that its board meeting was scheduled for October 30, 2026, to consider and approve standalone and consolidated unaudited results for the quarter and half year ended September 30, 2026. The supplied disclosures do not explain the difference between the snapshot date and the board-meeting schedule.

Why did revenue growth not translate into higher profit?

The available information does not identify the specific reasons for the decline in Q2 net profit despite higher revenue. Chembond has disclosed the revenue and profit comparison, but the supplied material does not provide a detailed cost, margin, exceptional-item, or segment-wise bridge for the September quarter.

The June-quarter operating figures show why quarterly profitability metrics require close reading. For Q1 FY27, consolidated net sales were ₹72.42 crore, up 0.93% sequentially from ₹71.75 crore. Operating profit before depreciation, interest and tax, excluding other income, was ₹2.98 crore, down 53.73% from ₹6.44 crore in the March 2026 quarter. Operating margin declined to 4.10% from 8.98% over the same comparison.

Chembond’s Q1 net profit was ₹5.73 crore, up 64.66% quarter on quarter and 43.61% year on year. That movement differs from the decline reported for Q2, underlining that revenue growth and profit movement have not tracked in the same direction across the two quarters disclosed.

How did Chembond perform in FY26 and Q1 FY27?

Chembond recorded FY26 consolidated revenue from operations of ₹250.07 crore, compared with ₹201.30 crore in FY25. Consolidated profit after tax was ₹12.89 crore, lower than ₹17.56 crore in the previous financial year, according to the company’s 51st annual report for the year ended March 31, 2026.

On a standalone basis, FY26 revenue from operations rose to ₹210.14 crore from ₹171.21 crore. Standalone profit after tax was ₹7.76 crore, against ₹17.22 crore in FY25. The annual-report figures show revenue expansion at both consolidated and standalone levels, while profit after tax declined from the preceding year.

Specialty Chemicals accounted for about 83% of FY26 consolidated revenue, while Animal Health contributed the remaining 17%. Chembond also reported cash of ₹9.41 crore and borrowings of ₹4.16 crore for the year. These segment and balance-sheet figures provide context for a business where specialty chemicals form the larger share of operations.

What are investors watching after the Q2 update?

Investors are watching the detailed Q2 and half-year financial results that Chembond’s board was scheduled to consider on October 30, 2026. The key disclosed issue is the gap between 31.1% revenue growth and the 54.2% fall in net profit. The full results can provide additional information on expenses, operating profitability, segment performance, and the standalone-consolidated comparison.

The company has also confirmed that its dematerialised equity shares remain listed on BSE and NSE. For the quarter ended September 30, 2026, Chembond said shares received for dematerialisation were cancelled and the depository was recorded as owner within 15 days of receipt, in line with SEBI Regulation 74(5).

For shareholders, the near-term focus remains on the formal quarterly disclosures rather than on projecting future earnings. The data currently available establishes higher Q2 revenue, lower Q2 profit, and an FY26 pattern in which revenue rose while consolidated profit after tax declined.

Conclusion

Chembond’s latest reported Q2 figures show a clear divergence between sales and earnings. Consolidated revenue increased to ₹95.7 crore from ₹73 crore, but net profit fell to ₹3.3 crore from ₹7.2 crore. The company’s FY26 results showed a similar broader pattern of higher consolidated revenue alongside lower annual profit after tax.

The next disclosed event to watch is the board meeting scheduled for October 30, 2026, for Q2 FY27 and half-year results. Those filings may clarify the factors behind the reported movement in profitability and provide a fuller view of Chembond’s operating performance.